healthNewsغير مصنف

Novartis’s Zykadia gets positive results, faces Roche pressure

ZURICH (Reuters) – Novartis’s Zykadia drug performed well against a rare form of lung cancer, the Swiss company said on Friday, citing a study it hopes will help it win expanded regulatory approval for the use of the drug.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى